ASX - By Stock
|
TUA |
Re:
Ann: Change of Registered Office
|
|
nudgie
|
2 |
771 |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
2
|
771
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: December 2022 Quarterly Activities Report and Appendix 4C
|
|
nudgie
|
35 |
13K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: September 2022 Quarterly Activities Report and Appendix 4C
|
|
nudgie
|
14 |
3.5K |
2 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
14
|
3.5K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Response to ASX Price Query
|
|
nudgie
|
40 |
10K |
2 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
40
|
10K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
nudgie
|
74 |
26K |
2 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
74
|
26K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
NOX CEO Interview on Orphan Drug Status
|
|
nudgie
|
12 |
6.5K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
12
|
6.5K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
NOX CEO Interview on Orphan Drug Status
|
|
nudgie
|
12 |
6.5K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
12
|
6.5K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: US FDA Investor Presentation
|
|
nudgie
|
14 |
6.8K |
2 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
14
|
6.8K
|
2
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
nudgie
|
139 |
84K |
1 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
139
|
84K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
nudgie
|
139 |
84K |
0 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
139
|
84K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Announces Leadership Transition
|
|
nudgie
|
26 |
10K |
10 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
26
|
10K
|
10
|
|
ASX - By Stock
|
NOX |
Re:
Wainwright Presentation Recording
|
|
nudgie
|
2 |
1.7K |
1 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
2
|
1.7K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2021 AGM Corporate Presentation
|
|
nudgie
|
10 |
4.2K |
7 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
10
|
4.2K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Retraction of Grant Announcement
|
|
nudgie
|
57 |
19K |
5 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
57
|
19K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Prediction
|
|
nudgie
|
9 |
2.4K |
8 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
9
|
2.4K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Sarcoma trial to start Nov 15
|
|
nudgie
|
15 |
5.0K |
4 |
31/10/21 |
31/10/21 |
ASX - By Stock
|
15
|
5.0K
|
4
|
|
ASX - By Stock
|
YBR |
Re:
Ann: YBR Investor Presentation
|
|
nudgie
|
18 |
6.2K |
3 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
18
|
6.2K
|
3
|
|
ASX - By Stock
|
YBR |
Re:
Ann: YBR Investor Presentation
|
|
nudgie
|
18 |
6.2K |
7 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
18
|
6.2K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Achieves Important U.S. Patent Claims
|
|
nudgie
|
16 |
5.1K |
2 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
16
|
5.1K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Pre-clinical Data Supports a Role for Veyonda in COVID-19
|
|
nudgie
|
12 |
4.7K |
1 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Pre-clinical Data Supports a Role for Veyonda in COVID-19
|
|
nudgie
|
12 |
4.7K |
2 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
12
|
4.7K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
nudgie
|
71 |
23K |
3 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
71
|
23K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i In Vivo Study Exploratory Analysis Results
|
|
nudgie
|
74 |
25K |
7 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
74
|
25K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Proactive webinar
|
|
nudgie
|
14 |
3.0K |
2 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
14
|
3.0K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
bull case
|
|
nudgie
|
116 |
38K |
0 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
116
|
38K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Patent news
|
|
nudgie
|
31 |
12K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
A note from GK
|
|
nudgie
|
7 |
3.0K |
3 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
7
|
3.0K
|
3
|
|
ASX - By Stock
|
NOX |
GK presents to Switzer Small & Micro Cap Conference March 2021
|
|
nudgie
|
0 |
380 |
5 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
0
|
380
|
5
|
|
ASX - By Stock
|
TPG |
Re:
Ann: Change of Officers
|
|
nudgie
|
67 |
40K |
1 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
67
|
40K
|
1
|
|
ASX - By Stock
|
NOX |
CEO Masterclass interview
|
|
nudgie
|
1 |
909 |
5 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
1
|
909
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: ASX Small-Mid Cap Conference Corporate Presentation
|
|
nudgie
|
4 |
1.7K |
3 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
NOX |
********* interview with Dr Graham Kelly re Lupin results
|
|
nudgie
|
2 |
1.2K |
22 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
2
|
1.2K
|
22
|
|
ASX - By Stock
|
TUA |
Re:
Ann: Investor Presentation - Interim Financial Report
|
|
nudgie
|
34 |
24K |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
34
|
24K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
LuPIN abstract
|
|
nudgie
|
33 |
10K |
1 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
CLH |
Re:
I thought we opened today?
|
|
nudgie
|
8 |
6.4K |
0 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
8
|
6.4K
|
0
|
|
ASX - By Stock
|
TUA Technology |
Re:
TUAS Singapore
|
|
nudgie
|
33 |
12K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
33
|
12K
|
2
|
|
ASX - By Stock
|
TPM |
Re:
Ann: Change of Director's Interest Notice
|
|
nudgie
|
18 |
6.9K |
0 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
18
|
6.9K
|
0
|
|
ASX - By Stock
|
TPM |
Re:
Ann: Change of Director's Interest Notice
|
|
nudgie
|
18 |
6.9K |
0 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
18
|
6.9K
|
0
|
|